2025 immunization update: addressing vaccine hesitancy and catch-up vaccinations
Mary Koslap-Petraco highlighted the need to address vaccine hesitancy, catch up on immunizations, and build trust with parents at the 2025 NAPNAP National Conference on Pediatric Health Care.
Food Insecurity and the Dangers of Infant Formula Dilution
FDA accepts NDA for SYD-101 to treat pediatric myopia
If approved, SYD-101 would be the first and only pharmaceutical option for the treatment of progression of pediatric myopia in the United States.
Demystifying Infant Formula
Glycemic control guidelines for critically ill children with Maureen Madden, DNP
At the 2025 NAPNAP National Conference, Maureen Madden, DNP, CPNP-AC, CCRN, FCCM, FAAN, provides the key takeaways and recommendations for glycemic control guidance, updated in 2024.
Baricitinib shows promise for adolescent alopecia areata in phase 3 trial
The study, known as BRAVE-AA-PEDS, was sponsored by Eli Lilly and Company and involved 257 adolescents aged 12 to under 18 years.
